Mir-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose

Stem Cells and Development

Volumn 21, Issue 10, 2012, Pages 1749-1760

  Kim, Yeon Jeong ^a,b   Hwang, Soo Hyun ^a,b   Lee, Sun Young ^a,b   Shin, Keun Koo ^a,b   Cho, Hyun Hwa ^a   Bae, Yong Chan ^a   Jung, Jin Sup ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GLUCOSE; MICRORNA; MICRORNA 486 5P; SILENT INFORMATION REGULATOR 1; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; BINDING SITE; BONE DEVELOPMENT; CELL AGING; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; METABOLIC DISORDER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

3' UNTRANSLATED REGIONS; ABDOMINAL FAT; BETA-GALACTOSIDASE; CELL AGING; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; MESENCHYMAL STEM CELLS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA INTERFERENCE; RNA, MESSENGER; SIRTUIN 1;

EID: 84862854402     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0429     Document Type: Article

References (54)

1. Hayflick L and PS Moorhead. (1961). The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621.
2. Hayflick L. (1965). The Limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37:614-636.
3. Anisimov VN. (1983). Carcinogenesis and aging. Adv Cancer Res 40:365-424.
4. Dick JE and JA Wright. (1982). Involvement of ribonucleotide reductase activity in the senescence of normal human diploid fibroblasts. Mech Ageing Dev 20:103-109.
5. Caplan AI and SP Bruder. (2001). Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259-264.
6. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
7. Petersen BE, WC Bowen, KD Patrene, WM Mars, AK Sullivan, N Murase, SS Boggs, JS Greenberger and JP Goff. (1999). Bone marrow as a potential source of hepatic oval cells. Science 284:1168-1170.
8. Schwartz RE, M Reyes, L Koodie, Y Jiang, M Blackstad, T Lund, T Lenvik, S Johnson, WS Hu and CM Verfaillie. (2002). Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109:1291-1302.
9. Trounson A, RG Thakar, G Lomax and D Gibbons. (2011). Clinical trials for stem cell therapies. BMC Med 9:52.
10. Ho AD, W Wagner and U Mahlknecht. (2005). Stem cells and ageing. The potential of stem cells to overcome agerelated deteriorations of the body in regenerative medicine. EMBO Rep 6:35-38.
11. Banfi A, A Muraglia, B Dozin, M Mastrogiacomo, R Cancedda and R Quarto. (2000). Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28:707-715.
12. Baxter MA, RF Wynn, SN Jowitt, JE Wraith, LJ Fairbairn and I Bellantuono. (2004). Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22:675-682.
13. Abdelmohsen K, Y Kuwano, HH Kim and M Gorospe. (2008). Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem 389:243-255.
14. Filipowicz W, SN Bhattacharyya and N Sonenberg. (2008). Mechanisms of post-transcriptional regulation by micro-RNAs: are the answers in sight? Nat Rev Genet 9:102-114.
15. Ambros V. (2004). The functions of animal microRNAs. Nature 431:350-355.
16. Lal A, HH Kim and K Abdelmohsen. (2008). p16(INK4a) translation suppressed by miR-24. PLoS One 3:e1864.
17. Marasa BS, S Srikantan and K Masuda. (2009). Increased MKK4 abundance with replicative senescence is linked to the joint reduction of multiple microRNAs. Sci Signal 2: ra69.
18. Menghini R, V Casagrande, M Cardellini, E Martelli, A Terrinoni, F Amati, M Vasa-Nicotera, A Ippoliti, G Novelli, et al. (2009). MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120:1524-1532.
19. Zhao T, J Li and AF Chen. (2010). MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab 299:110-116.
20. Wagner W, P Horn and M Castoldi. (2008). Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3:e2213.
21. Bork S, P Horn,MCastoldi, I Hellwig,ADHo andWWagner. (2011). Adipogenic differentiation of human mesenchymal stromal cells is down-regulated by microRNA-369-5p and up-regulated by microRNA-371. J Cell Physiol 226:2226-2234.
22. Loomans CJ, EJ de Koning, FJ Staal, MB Rookmaaker, C Verseyden, HC de Boer, MC Verhaar, B Braam, TJ Rabelink and AJ van Zonneveld. (2004). Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53:195-199.
23. Chen YH, SJ Lin, FY Lin, TC Wu, CR Tsao, PH Huang, PL Liu, YL Chen and JW Chen. (2007). High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 56:1559-1568.
24. Kim HK, YJ Kim, JT Kim, CH Kwon, YK Kim, YC Bae, DH Kim and JS Jung. (2008). Alterations in the proangiogenic functions of adipose tissue-derived stromal cells isolated from diabetic rats. Stem Cells Dev 17:669-680.
25. Cho HH, YC Bae and JS Jung. (2006). Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 24:2744-2752.
26. Lee RH, B Kim, I Choi, H Kim, HS Choi, K Suh, YC Bae and JS Jung. (2004). Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14:311-324.
27. Kim YJ, SJ Hwang, YC Bae and JS Jung. (2009). MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 27:3093-3102.
28. Escande C, CC Chini, V Nin, KM Dykhouse, CM Novak, J Levine, J van Deursen, GJ Gores, J Chen, Z Lou and EN Chini. (2010). Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. J Clin Invest 120:545-558.
29. Krützfeldt J, MN Poy and M Stoffel. (2006). Strategies to determine the biological function of microRNAs. Nat Genet 38:14-19.
30. Cohen HY, C Miller, KJ Bitterman, NR Wall, HB ekking, B Kessler, KT Howitz, M Gorospe, R de Cabo and DA Sinclair. (2004). Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305:390-392.
31. Milne JC, PD Lambert, S Schenk, DP Carney, JJ Smith, DJ Gagne, L Jin, O Boss, RB Perni, et al. (2007). Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450:712-716.
32. Campisi J. (2005). Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120: 513-522.
33. Guarente L and F Picard. (2005). Calorie restriction-the SIR2 connection. Cell 120:473-482.
34. Guarente L and C Kenyon. (2000). Genetic pathways that regulate ageing in model organisms. Nature 408:255-262.
35. Kaeberlein M, M McVey and L Guarente. (1999). The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13:2570-2580.
36. Langley E, M Pearson, M Faretta, UM Bauer, RA Frye, S Minucci, PG Pelicci and T Kouzarides. (2002). Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO 21:2383-2396.
37. Ota H, M Akishita, M Eto, K Iijima, M Kaneki and Y Ouchi. (2007). Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 43:571-579.
38. van der Veer E, C Ho, C O'Neil, N Barbosa, R Scott, SP Cregan and JG Pickering. (2007). Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J Biol Chem 282:10841-10845.
39. Chen WY, DH Wang, RC Yen, J Luo, W Gu and SB Baylin. (2005). Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123:437-448.
40. Pediconi N, F Guerrieri, S Vossio, T Bruno, L Belloni, V Schinzari, C Scisciani, M Fanciulli and M Levrero. (2009). hSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damage. Mol Cell Biol 298:1989-1998.
41. Oberdoerffer P, S Michan, M McVay, R Mostoslavsky, J Vann, SK Park, A Hartlerode, J Stegmuller, A Hafner, et al. (2008). SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135:907-918.
42. Firestein R, G Blander, S Michan, P Oberdoerffer, S Ogino, J Campbell, A Bhimavarapu, S Luikenhuis, R de Cabo, et al. (2008). The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 3:e2020.
43. Wang RH, K Sengupta, C Li, HS Kim, L Cao, C Xiao, S Kim, X Xu, Y Zheng, et al. (2008). Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 14:312-323.
44. Zu Y, L Liu, MY Lee, C Xu, Y Liang, RY Man, PM Vanhoutte and Y Wang. (2010). SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ Res 106:1384-1393.
45. Rathbone CR, FW Booth and SJ Lees. (2009). Sirt1 increases skeletal muscle precursor cell proliferation. Eur J Cell Biol 88:35-44.
46. Cramer C, E Freisinger, RK Jones, DP Slakey, CL Dupin, ER Newsome, EU Alt and R Izadpanah. (2010). Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev 19:1875-1884.
47. Balestrieri ML, M Rienzo, F Felice, R Rossiello, V Grimaldi, L Milone, A Casamassimi, L Servillo, B Farzati, A Giovane and C Napoli. (2008). High glucose downregulates endothelial progenitor cell number via SIRT1. Biochim Biophys Acta 1784:936-945.
48. Retaken J, N Yaluri, S Modi, J Pihlajamä ki, M Vä nttinen, P Itkonen, S Kainulainen, H Yamamoto, M Lagouge, et al. (2010). SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity. Diabetes 59:829-835.
49. Feige JN, M Lagouge, C Canto, A Strehle, SM Houten, JC Milne, PD Lambert, C Mataki, PJ Elliott and J Auwerx. (2008). Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 8:347-358.
50. Haigis MC and LP Guarente. (2006). Mammalian sirtuinsemerging roles in physiology, aging, and calorie restriction. Genes Dev 20:2913-2921.
51. Howitz KT, KJ Bitterman, HY Cohen, DW Lamming, S Lavu, JG Wood, RE Zipkin, P Chung, A Kisielewski, et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-196.
52. Baur JA, KJ Pearson, NL Price, HA Jamieson, C Lerin, A Kalra, VV Prabhu, JS Allard, G Lopez-Lluch, et al. (2006). Resveratrol improves health and survival of mice on a highcalorie diet. Nature 444:337-342.
53. Lagouge M, C Argmann, Z Gerhart-Hines, H Meziane, C Lerin, F Daussin, N Messadeq, J Milne, P Lambert, et al. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109-1122.
54. Gan L, H Matsuura, T Ichiki, X Yin, R Miyazaki, T Hashimoto, J Cui, K Takeda and K Sunagawa. (2009). Improvement of neovascularization capacity of bone marrow mononuclear cells from diabetic mice by ex vivo pretreatment with resveratrol. Hypertens Res 32:542-547.